Kai Yao

机构：Sun Yat-sen University, Key Laboratory of Guangdong Province, Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou), Sun Yat-sen University Cancer Center, Guangdong Provincial People's Hospital, Southern Medical University · ORCID：0000-0002-2589-3058

发表论文 126 篇 · 总被引 2103 次 · h-index 25

代表论文

• Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer (2025 · New England Journal of Medicine · 被引 78)
• Neoadjuvant toripalimab plus nimotuzumab combined with taxol-based chemotherapy in locally advanced penile squamous cell carcinoma (2025 · Cancer Cell · 被引 18)
• Human papillomavirus infection affects treatment outcomes and the immune microenvironment in patients with advanced penile squamous cell carcinoma receiving programmed cell death protein 1 inhibitor–based combination therapy (2023 · Cancer · 被引 16)
• Nectin-4 targeted ADC, SHR-A2102, in patients with advanced or metastatic urothelial carcinoma: A phase 1 study. (2025 · Journal of Clinical Oncology · 被引 8)
• Differentiating between adrenocortical carcinoma and pheochromocytoma by a CT-based radiomics model: a multicenter retrospective study (2025 · BMC Medical Imaging · 被引 6)
• Development and Validation of a Contrast-Enhanced US VI-RADS for Evaluating Muscle Invasion in Bladder Cancer (2024 · Radiology · 被引 6)